Kouya Shiraishi

36PUBLICATIONS
205CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jun 12, 2026
Recurrent COPA mutation drives R-spondin-independent Wnt activation in intestinal tumors.

|Jun 02, 2026
Role of VEGFA/VEGFR2 signaling in predicting clinical outcomes of EGFR-TKI treatment in EGFR-mutant non-small cell lung cancer.

|Apr 11, 2026
Microbiomic and immunogenic biomarkers of adjuvant chemotherapy efficacy in stage III colorectal cancer.

Erika Machida, Yasuyuki Takamizawa, Daisuke Takayanagi

|Feb 26, 2026
Gastric-Type Cervical Adenocarcinoma: Clinicopathologic Features, Molecular Landscape, and Therapeutic Challenges.

Hiroshi Yoshida, Daiki Higuchi, Waku Takigawa

|Jan 15, 2026
Comprehensive Genomic Profiling of Advanced Anal Adenocarcinoma in Japan.

Nozomu Ogura, Hidekazu Hirano, Kouya Shiraishi

|Jan 10, 2026
Evaluation of NTRK Fusions Detection Method in Esophageal Squamous Cell Carcinoma and Gastric Adenocarcinoma.

Tomoyuki Momma, Motonobu Saito, Shotaro Nakajima

Pageof 6

Frequent Collaborators

15 joint publications

Takashi Kohno

11 joint publications

Ryuji Hamamoto

8 joint publications

Hiroshi Yoshida

6 joint publications

Hidehito Horinouchi